bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • Citius Oncology Inc. logo

    Citius Oncology Inc.

    CTOR | NASDAQ
    Chart Builder DCF Calculator
    $1.05
    +$0.01 (+0.48%)
    At close: Sep 22, 2026, 3:59 PM ET
    $1.07
    +$0.02 (+1.90%)
    After-hours: Sep 22, 2026, 7:30 PM ET
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $97.17M
    Enterprise Value
    $90.81M
    Beta
    3.53
    Average Volume
    80.31K
    Shares Outstanding (Diluted)
    107.89M
    Shares Change YoY
    50.79%
    Institutional Ownership
    14.24%
    Exchange
    NASDAQ
    ISIN
    US17331Y1091

    Price Performance

    Price Change 1M
    36.8%
    Price Change 3M
    51.8%
    Price Change 6M
    79.9%
    Price Change YTD
    -3.7%
    Price Change 1Y
    -41.6%
    Price Change 3Y
    -90.9%
    Price Change 5Y
    -90.9%
    1M CAGR (ann.)
    39.4%
    1Y CAGR (ann.)
    -40.0%
    5Y CAGR (ann.)
    N/A
    All-Time CAGR
    -66.8%

    Valuation

    PE Ratio
    -2.17
    Forward PE
    13.26
    PEG Ratio
    0.05
    Forward PEG
    0.02
    PS Ratio
    13.68
    Forward PS
    1.00
    PB Ratio
    2.41
    P/FCF Ratio
    -4.93
    P/Adj. FCF Ratio
    -4.93
    P/OCF Ratio
    -5.78
    EV/Sales
    12.78
    EV/EBIT
    -2.00
    EV/EBITDA
    -2.11
    EV/FCF
    -4.61
    Earnings Yield
    -46.1%
    FCF Yield
    -20.3%
    Adj. FCF Yield
    -20.3%

    Financial Health

    Net Cash
    $6.35M
    Total Debt
    $10.21M
    Cash & Short-Term Investments
    $16.56M
    Total Assets
    $112.09M
    Current Ratio
    0.73
    Quick Ratio
    0.34
    Debt / Equity Ratio
    0.25
    Debt / EBITDA
    -0.24
    Debt / FCF
    -0.52
    OCF / Debt
    -1.93
    Interest Coverage
    -86.40
    Altman Z-Score
    -1.95
    Piotroski F-Score
    3

    Margins & Profitability

    Gross Profit Margin
    53.1%
    Operating Profit Margin
    -665.6%
    EBITDA Margin
    -607.0%
    Net Profit Margin
    -648.3%
    FCF Margin
    -277.3%
    Adj. FCF Margin
    -277.3%
    SBC / Revenue
    0.0%
    SBC Impact (per share)
    N/A

    Returns

    Return on Assets
    -41.1%
    Return on Equity
    -103.0%
    Return on Invested Capital
    -88.7%
    Return on Capital Employed
    -88.7%
    Return on Tangible Assets
    -107.9%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    150.0%
    Revenue CAGR 5Y
    N/A
    Revenue CAGR 10Y
    N/A
    EPS CAGR 3Y
    9.4%
    EPS CAGR 5Y
    N/A
    EPS CAGR 10Y
    N/A
    FCF CAGR 3Y
    -143.5%
    FCF CAGR 5Y
    N/A
    FCF CAGR 10Y
    N/A

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    2
    EPS Growth Next 3Y
    70.1%
    Revenue Growth Next 3Y
    192.1%
    Earnings Date
    Dec 16, 2026
    EPS Estimate (next Q)
    -$0.19
    EPS Growth Est (next Q)
    216.7%
    Revenue Est (next Q)
    $5.77M
    Revenue Growth Est (next Q)
    N/A

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $6
    Price Target Upside
    476.9%

    Cash Flow

    Operating Cash Flow
    $-19.71M
    Free Cash Flow
    $-19.71M
    Adj. Free Cash Flow
    $-19.71M
    FCF Per Share
    -$0.18
    OCF Per Share
    -$0.18
    OCF/S Ratio
    -277.3%

    Income Statement

    Revenue
    $7.11M
    Gross Profit
    $3.77M
    Operating Income
    $-47.29M
    EBITDA
    $-43.13M
    Net Income
    $-46.06M
    EPS (Diluted)
    -$0.48
    Revenue / Employee
    $24.93K
    Profit / Employee
    $-161.63K
    Employees
    285

    © 2026 bestshares.com. All rights reserved.